Bg pattern

CHICLIDA 25 mg LOZENGES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CHICLIDA 25 mg LOZENGES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Chiclida 25 mg lozenges

Meclozine hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist even if it is a side effect not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 7 days.

Contents of the package leaflet:

  1. What is Chiclida and what is it used for
  2. What you need to know before taking Chiclida
  3. How to take Chiclida
  4. Possible side effects
  5. Storage of Chiclida
  6. Contents of the pack and further information

1. What is Chiclida and what is it used for

Meclozine hydrochloride, the active substance of Chiclida, belongs to the group of medicines called antihistamines, used against motion sickness.

Chiclida is indicated for the prevention and treatment of symptoms of motion sickness caused by land, sea, or air travel, such as nausea, vomiting, and/or vertigo in adults and adolescents over 12 years of age.

You should consult a doctor if it worsens or does not improve after 7 days.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Chiclida

Do not take Chiclida

  • If you are allergic to Meclozine hydrochloride or to any of the other components of this medicine (listed in section 6).
  • If you have increased intraocular pressure (glaucoma).
  • If you have prostate enlargement (prostatic hypertrophy).
  • If you have a disease that causes obstruction of the gastrointestinal or urinary tract.
  • If you have asthma.
  • If you have diabetes.
  • Children under 6 years of age.

Warnings and precautions

Consult your doctor or pharmacist before taking Chiclida:

  • If you have seizures with convulsive movements, with or without loss of consciousness (epilepsy).
  • If you are over 65 years old, dry mouth, urinary retention, glaucoma, nausea, dizziness, sedation, confusion, low blood pressure (hypotension), or hyperexcitability may occur.
  • If you are taking any medication that causes ear toxicity, as symptoms of these toxic effects, such as ringing in the ears, dizziness, or vertigo, may be masked.
  • If you have any liver or kidney disease or disorder, as the concentration of the active substance may increase.
  • If you have any heart disease or disorder, such as cardiac arrhythmia, hypertension, severe muscle weakness (myasthenia gravis), stomach or intestinal ulcers.
  • If you suspect you have symptoms of appendicitis, such as nausea, vomiting, or abdominal cramps. It is recommended to consult a doctor to rule out the presence or absence of appendicitis.

Avoid exposure to the sun while taking this medicine.

If you are allergic to any other antihistamine, it is not recommended to take this medicine.

Interference with laboratory tests

If you are going to have a skin test that uses allergens, inform your doctor that you are taking this medicine, as it may alter the results.

It is recommended to stop taking this medicine at least 72 hours before the test.

Children

Do not use this medicine in children under 12 years of age.

Using Chiclida with other medicines

Inform your doctor or pharmacist if you are taking, have recently taken, or may take any other medicine.

The following are not recommended to be taken in combination with Chiclida:

  • Central nervous system depressants, such as anesthetics, opioid analgesics, barbiturates (used as sedatives, anticonvulsants, and for sleep disorders), benzodiazepines (for sleep), antipsychotics.
  • Antiparkinsonian medicines.
  • Antidepressants.
  • Neuroleptics (used to calm excitement and neuromuscular hyperactivity).

Taking Chiclida with food, drinks, and alcohol

Alcoholic beverages may enhance the effect of Meclozine, so it is not recommended to take them simultaneously.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medicine.

It should not be used during pregnancy, unless strictly necessary. Do not administer during breastfeeding.

Driving and using machines

Chiclida may cause drowsiness, which may affect your ability to drive and/or operate machines. Patients should avoid operating hazardous machinery, including automobiles, until they know how they tolerate the medicine.

Chiclida contains glucose and sucrose

This medicine contains glucose and sucrose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.

It may cause tooth decay.

3. How to take Chiclida

Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor. In case of doubt, ask your doctor or pharmacist.

Adults and adolescents (over 12 years of age): 1 or 2 lozenges of Chiclida (25 mg - 50 mg meclozine hydrochloride) approximately 1 hour before starting the trip. If necessary, repeat the dose every 24 hours. Do not exceed the dose of 2 lozenges of Chiclida (50 mg of meclozine hydrochloride) per day.

Patient with renal and/or hepatic insufficiency: It may be necessary to reduce the dose (see section 2 Warnings and precautions).

Suck the lozenge. Do not swallow.

Administer at least 1 hour before starting the trip.

If the symptoms worsen or persist for more than 7 days, you should consult a doctor.

Use in children

Chiclida is contraindicated in children under 6 years of age.

It is not recommended to administer this medicine to children between 6 and 12 years of age.

If you take more Chiclida than you should

You should consult your doctor or pharmacist immediately.

The symptoms of an overdose may vary, from sedation, difficulty breathing, loss of consciousness to insomnia, hallucinations, tremors, or convulsions.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Chiclida

Do not take a double dose to make up for forgotten doses.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you think any of the side effects you are experiencing are serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

If you have a severe allergic reaction (anaphylactic shock) with rash, itching, difficulty breathing, stop taking the medicine and seek medical help immediately.

The most common side effects are drowsiness and sedation. Dry mouth, blurred vision, nausea, vomiting, and joint pain occur rarely (may affect up to 1 in 1,000 patients).

Other side effects of unknown frequency (cannot be estimated from the available data) are:

  • Abdominal pain, diarrhea, and constipation.
  • Sleepiness and sedation.
  • Increased bronchial secretion.
  • Increased appetite, anorexia.
  • Anxiety, euphoria, irritability, hallucinations, insomnia, memory disorders, psychotic disorders, confusion, and paranoia.
  • Dizziness, headache, movement disorders (e.g., Parkinson's disease), paresthesia (tingling and numbness sensation).
  • Double vision.
  • Vertigo, tinnitus (internal ear noises).
  • Dry throat and nose, bronchospasm (contraction of the bronchi), epistaxis (nosebleed).
  • Dysuria (difficult, painful, and incomplete urination), polyuria (production and excretion of large amounts of urine), urinary retention.
  • Fatigue, weakness.
  • Tachycardia, palpitations, and/or arrhythmias.
  • Hypotension (decreased blood pressure).
  • Hyperexcitability may occur, especially in children.
  • Decrease in the number of red blood cells, white blood cells, leukocytes, and platelets in the blood.
  • Allergic reactions on the skin and sensitivity to sunlight, after intense exposure, which may cause itching and redness of the skin.
  • Weight gain.

Reporting of side effects

If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Chiclida

No special storage conditions are required.

Keep out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the pack and further information

Composition of Chiclida

The active substance is Meclozine hydrochloride. Each lozenge contains 25 mg of meclozine hydrochloride.

The other ingredients are: glucose monohydrate, sucrose, peppermint flavor, and magnesium stearate. See section 2 "Chiclida contains glucose and sucrose".

Appearance of the product and pack contents

Oval-shaped lozenges, white in color.

Each pack contains 6 lozenges.

Marketing authorization holder and manufacturer

Marketing authorization holder

Name: Fleer Española, S.L.

Address: Rambla Catalunya Nº. 53 ático

City: 08007-Barcelona

Manufacturer:

Name: Fleer Española, S.L.

Address: 08795 – Olesa de Bonesvalls (Barcelona) Phone: 93 898 40 11 Fax: 93 898 41 76

Date of the last revision of this leaflet: January 2015

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)

http://aemps.gob.es

Online doctors for CHICLIDA 25 mg LOZENGES

Discuss questions about CHICLIDA 25 mg LOZENGES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
0.0 (0)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance.

His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation.

Patients commonly consult Dr Daniel Cichi for:

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.
Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.
Camera Book a video appointment
€55
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59

Frequently Asked Questions

Is a prescription required for CHICLIDA 25 mg LOZENGES?
CHICLIDA 25 mg LOZENGES does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CHICLIDA 25 mg LOZENGES?
The active ingredient in CHICLIDA 25 mg LOZENGES is meclozine. This information helps identify medicines with the same composition but different brand names.
Who manufactures CHICLIDA 25 mg LOZENGES?
CHICLIDA 25 mg LOZENGES is manufactured by Fleer Española S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CHICLIDA 25 mg LOZENGES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CHICLIDA 25 mg LOZENGES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CHICLIDA 25 mg LOZENGES?
Other medicines with the same active substance (meclozine) include CHICLIDA 25 mg MEDICATED CHEWING GUMS, ALERCINA 10 mg TABLETS, ALERLISIN 1 mg/ml ORAL SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media